ES461918A1 - Un procedimiento para la obtencion de un preparado fomenta- dor de la coagulacion de la sangre a base de plasma sangui- neo humano. - Google Patents

Un procedimiento para la obtencion de un preparado fomenta- dor de la coagulacion de la sangre a base de plasma sangui- neo humano.

Info

Publication number
ES461918A1
ES461918A1 ES461918A ES461918A ES461918A1 ES 461918 A1 ES461918 A1 ES 461918A1 ES 461918 A ES461918 A ES 461918A ES 461918 A ES461918 A ES 461918A ES 461918 A1 ES461918 A1 ES 461918A1
Authority
ES
Spain
Prior art keywords
coagulation
blood
feiba
producing
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES461918A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oesterreichisches Institut fuer Haemoderivate
Original Assignee
Immuno AG
Immuno AG fuer Chemisch Medizinische Produkte
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno AG, Immuno AG fuer Chemisch Medizinische Produkte filed Critical Immuno AG
Publication of ES461918A1 publication Critical patent/ES461918A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/28—Bound to a nonpeptide drug, nonpeptide label, nonpeptide carrier, or a nonpeptide resin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • External Artificial Organs (AREA)
ES461918A 1976-08-30 1977-08-26 Un procedimiento para la obtencion de un preparado fomenta- dor de la coagulacion de la sangre a base de plasma sangui- neo humano. Expired ES461918A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT640576A AT350726B (de) 1976-08-30 1976-08-30 Verfahren zur herstellung einer blut- gerinnungsfoerdernden praeperation aus menschlichem blutplasma

Publications (1)

Publication Number Publication Date
ES461918A1 true ES461918A1 (es) 1978-12-16

Family

ID=3585985

Family Applications (1)

Application Number Title Priority Date Filing Date
ES461918A Expired ES461918A1 (es) 1976-08-30 1977-08-26 Un procedimiento para la obtencion de un preparado fomenta- dor de la coagulacion de la sangre a base de plasma sangui- neo humano.

Country Status (17)

Country Link
US (1) US4160025A (OSRAM)
AR (1) AR213861A1 (OSRAM)
AT (1) AT350726B (OSRAM)
BE (1) BE858031A (OSRAM)
CA (1) CA1079191A (OSRAM)
CH (1) CH635747A5 (OSRAM)
DE (1) DE2734821C3 (OSRAM)
DK (1) DK151932C (OSRAM)
ES (1) ES461918A1 (OSRAM)
FI (1) FI57421C (OSRAM)
FR (1) FR2362633A1 (OSRAM)
GB (1) GB1554051A (OSRAM)
HU (1) HU180816B (OSRAM)
LU (1) LU78024A1 (OSRAM)
NL (1) NL170922C (OSRAM)
NO (1) NO148142C (OSRAM)
SE (1) SE443511B (OSRAM)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2902158A1 (de) * 1979-01-20 1980-07-31 Biotest Serum Institut Gmbh Verfahren zur herstellung von fibrinogen, einem die gerinnungsfaktoren ii, vii, ix und x enthaltenden prothrombinkomplex, antithrombin iii und einer loesung von lagerstabilen serumproteinen
US4286056A (en) * 1980-01-28 1981-08-25 Baxter Travenol Laboratories, Inc. Method for making therapeutic enzyme compositions
WO1981002105A1 (en) * 1980-01-28 1981-08-06 Baxter Travenol Lab Therapeutic compositions & methods for manufacture and use
US4287180A (en) * 1980-01-28 1981-09-01 Baxter Travenol Laboratories, Inc. Method for treating blood clotting factor inhibitors
EP0035204B2 (en) * 1980-03-05 1991-05-22 Miles Inc. Pasteurized therapeutically active protein compositions
US4404132A (en) * 1980-05-27 1983-09-13 Cutter Laboratories, Inc. Blood coagulation promoting product
US4361510A (en) * 1980-05-27 1982-11-30 Cutter Laboratories, Inc. Blood coagulation promoting product
US4364861A (en) * 1980-05-27 1982-12-21 Cutter Laboratories, Inc. Blood-coagulation-promoting products and methods of preparing them
DE3172210D1 (en) * 1980-05-27 1985-10-17 Miles Lab Blood coagulation promoting product and process of preparing same
US4391746A (en) * 1980-05-27 1983-07-05 Cutter Laboratories, Inc. Blood-coagulation-promoting products and methods of preparing them
AT368883B (de) * 1980-07-22 1982-11-25 Immuno Ag Verfahren zur herstellung einer neuen blutgerinnungsfoerdernden praeparation auf basis von humanproteinen
DE3101752A1 (de) * 1981-01-21 1982-08-26 Behringwerke Ag, 3550 Marburg "verfahren zur reinigung der blutgerinnungsfaktoren ii, vii, ix und/oder x und danach hergestellte praeparationen"
US4479938A (en) * 1981-06-25 1984-10-30 Baxter Travenol Laboratories, Inc. Therapeutic composition containing factor VIIa
US4382083A (en) * 1981-06-25 1983-05-03 Baxter Travenol Laboratories, Inc. Therapeutic method for treating blood-clotting defects with factor VIIa
JPS5866054A (ja) * 1981-10-14 1983-04-20 Sekisui Chem Co Ltd 血液検査用容器
JPS58105064A (ja) * 1981-12-17 1983-06-22 Sekisui Chem Co Ltd 血液凝固促進剤
AT389815B (de) * 1984-03-09 1990-02-12 Immuno Ag Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern in blutprodukten
DE3625090A1 (de) * 1986-07-24 1988-01-28 Behringwerke Ag Mittel zur therapie faktor viii-resistenter haemophilie a und verfahren zu seiner herstellung
CA1330302C (en) * 1988-01-18 1994-06-21 Miroslav Rybak Concentrates of coagulation factors ii, vii, ix and x, method of their preparation and use
AT402891B (de) * 1991-06-20 1997-09-25 Immuno Ag Verfahren zur herstellung eines inaktivierten blutproduktes
AT398079B (de) * 1991-11-04 1994-09-26 Immuno Ag Präparation mit thrombinaktivität sowie verfahren zu ihrer herstellung
AT399818B (de) * 1992-04-24 1995-07-25 Immuno Ag Verfahren zur herstellung einer hochgereinigten virussicheren faktor viii-präparation
WO1994013329A1 (de) * 1992-12-16 1994-06-23 Immuno Aktiengesellschaft Verfahren zur herstellung eines virussicheren biologischen präparates
DE4320294A1 (de) * 1993-06-18 1994-12-22 Immuno Ag Verwendung von humanem Protein C zur Verhinderung und Behandlung von Thrombozytenablagerungen
US5677162A (en) * 1995-05-01 1997-10-14 New York Blood Center, Inc. Method for activating prothrombin to thrombin
DE19531637A1 (de) * 1995-08-28 1997-03-06 Immuno Ag Pharmazeutische Zusammensetzung zur Behandlung von Blutgerinnungsstörugnen, Verfahren zur Herstellung derselben und deren Verwendung
CZ81997A3 (en) * 1996-03-20 1997-10-15 Immuno Ag Pharmaceutical preparation for treating disorders connected with blood clotting, process of its preparation and use
AT405485B (de) 1997-05-28 1999-08-25 Immuno Ag Eine das vwf-propeptid enthaltende pharmazeutische präparation
AT407484B (de) * 1997-11-12 2001-03-26 Bio Prod & Bio Eng Ag Arzneimittel zur förderung der wundheilung
RS20050051A (sr) * 2002-07-23 2007-06-04 Bio-Products & Bio Engineering Ag., Farmaceutski aktivni sastojak preparata i medikamenata koji sadrže trombin ili imaju mogućnost stvaranja trombina
AU2003246448A1 (en) * 2002-07-23 2004-02-16 Bio-Products And Bio-Engineering Aktiengesellschaft Pharmaceutically active substance preparations and drugs that are capable of generating thrombin and/or that contain thrombin
EP2305289A1 (en) 2009-09-16 2011-04-06 Bio-Products & Bio-Engineering Aktiengesellschaft Medicinal products for the treatment of blood coagulation disorders
IS2809B (is) * 2011-03-08 2012-10-15 Haskoli Islands Blóðstorkumæling
RU2648517C1 (ru) * 2017-06-23 2018-03-26 Федеральное государственное бюджетное учреждение Гематологический научный центр Министерства здравоохранения Российской Федерации (ФГБУ ГНЦ Минздрава России) Способ получения лиофилизированного препарата активированного протромбинового комплекса, обладающего фактор viii-шунтирующей активностью
JP2022041059A (ja) * 2020-08-31 2022-03-11 シスメックス株式会社 検量線の表示方法および分析装置
WO2024012853A1 (de) 2022-07-12 2024-01-18 Biomedizinische Forschung & Bio-Produkte AG Arzneimittel zur förderung der hämostase

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2262520C3 (de) * 1972-12-20 1987-02-12 Miles Laboratories, Inc., Elkhart, Ind. Verfahren zur Herstellung eines lyophilisierten, lagerfähigen Konzentrats aus menschlichem Plasma
DE2459291C3 (de) * 1974-12-14 1981-06-04 Biotest-Serum-Institut Gmbh, 6000 Frankfurt Verfahren zur Herstellung eines antihämophiles Globulin A enthaltenden Konzentrats neben einem Prothrombin- Komplex und einer Lösung von lagerstabilen Serumproteinen
US3998946A (en) * 1975-04-23 1976-12-21 The Regents Of The University Of Minnesota Fibrinogen-free plasminogen-plasmin-free plasma and method of preparing and using same
DD121793A1 (OSRAM) * 1975-07-17 1976-08-20
US4027013A (en) * 1976-01-22 1977-05-31 William L. Wilson Clottable fibrinogen free factor VIII and albumin product and process

Also Published As

Publication number Publication date
GB1554051A (en) 1979-10-17
NL170922B (nl) 1982-08-16
SE7707992L (sv) 1978-03-01
FI772408A7 (fi) 1978-03-01
FR2362633B1 (OSRAM) 1981-06-12
DK151932C (da) 1988-06-20
FI57421C (fi) 1980-08-11
HU180816B (en) 1983-04-29
FI57421B (fi) 1980-04-30
DK151932B (da) 1988-01-18
LU78024A1 (OSRAM) 1978-01-11
DK384577A (da) 1978-03-01
NO148142B (no) 1983-05-09
AT350726B (de) 1979-06-11
BE858031A (fr) 1977-12-16
NO148142C (no) 1983-08-17
NL7708872A (nl) 1978-03-02
DE2734821B2 (de) 1980-11-06
ATA640576A (de) 1978-11-15
CA1079191A (en) 1980-06-10
DE2734821A1 (de) 1978-03-02
NL170922C (nl) 1983-01-17
DE2734821C3 (de) 1985-03-14
FR2362633A1 (fr) 1978-03-24
NO772978L (no) 1978-03-01
AR213861A1 (es) 1979-03-30
US4160025A (en) 1979-07-03
CH635747A5 (de) 1983-04-29
SE443511B (sv) 1986-03-03

Similar Documents

Publication Publication Date Title
ES461918A1 (es) Un procedimiento para la obtencion de un preparado fomenta- dor de la coagulacion de la sangre a base de plasma sangui- neo humano.
GB2181348B (en) Controlled release metoprolol preparations
MY100729A (en) Food process
MY109990A (en) Microfluidised particles of atovaquone and pharmaceutical preparation thereof
HUT43091A (en) Process for producing mannosyl-aglycon of antibiotic a 40926
ES450208A1 (es) Un metodo de preparacion de una gamma-globulina anti-hbs a partir de plasma humano.
EP0137356A3 (en) Covalently bound heparin - antithrombin-iii complex, method for its preparation and its use for treating thromboembolism
DE2960213D1 (en) Process for the preparation of saturated aliphatic, cycloaliphatic and araliphatic aldehydes
ES8302016A1 (es) Procedimiento para tratar fracciones individuales de plasma sanguineo.
ES8404693A1 (es) Procedimiento de preparacion de nuevos amino-14 esteroides.
JPS5328509A (en) Treating method for increasing high temperature strength of pure titanium material
HU900525D0 (en) Process for the production of medical preparations for treating endotoxinemy
JPS523524A (en) Cu alloy of high strength and electric conductivity
JPS5265973A (en) Process for treating water containing phosphate and sulfate ions
JPS524637A (en) Dental correcting fittings made of polyurethane resin and manufacturin g method
JPS5237153A (en) Method of transplantation of hairs to human skin
JPS5239573A (en) Process for destroying the texture of the animal fibrous material by s welling and softening
JPS51136359A (en) Compound waste water treating material
JPS5388390A (en) Preparation of fibrinolytic solid surface
JPS51119165A (en) Treating method of chromium-containing waste water
JPS533534A (en) Local anesthetics
JPS53144818A (en) Free cutting nickel-chromium alloy and manufacture thereof
JPS5224187A (en) Treatment of aluminum-sludge including phosphorus
JPS51124050A (en) Treatment method of waste water containing formaldehyde
JPS5532545A (en) Particle accelerator for medical treatment